Published • loading... • Updated
U.S. National Library of Medicine Updates Clinical Documentation for Adasuve Inhalation Powder
Summary by GeneOnline News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
U.S. National Library of Medicine Updates Clinical Documentation for Adasuve Inhalation Powder
The U.S. National Library of Medicine updated its clinical documentation for Adasuve (loxapine) inhalation powder on October 5, 2026. The medication, manufactured by Alexza Pharmaceuticals, Inc., serves as a treatment for agitation associated with schizophrenia or bipolar I disorder in adults. The updated record provides standardized prescribing information, safety protocols, and administration guidelines for healthcare providers managing patien…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
